Roger P Friedenthal, MD
Plastic and Reconstructive Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 2 carriers
- Offices
- 2
- Since medical school
- 64 years
- Yale University School of Medicine, 1962
Offices
2 locations · Hyperbaric Consultants Medical Group Inc · Csi Medical Group
Looking this up.
Plans that list them
16 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Friedenthal’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G9257 · Current
Licensed to practise in California · since 1963 · expires 2028-10-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Plastic Surgery - Plastic Surgery
Original Medicare doctor bills
$95,998
Medicare paid this office $95,998 for 58 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 12 | $61,219 | $201 |
| Return visit (30+ min) | 23 | $8,412 | $122 |
| Short return visit (20+ min) | 31 | $8,264 | $80 |
| Management of oxygen chamber therapy | 12 | $6,560 | $91 |
| Removal of tissue from wound, 20.0 sq cm or less | 15 | $4,872 | $102 |
Procedures Medicare counted
| Mastectomy | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 34 | More than 75% of doctors who do this |
Who their Medicare patients are
58 Original Medicare patients in 2024. Average age 75 · Women 59% · Also on Medicaid 33% · Health risk score 2.55. Sicker patients than 9 in 10 peers; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: High blood pressure 74% · Depression 38% · Coronary heart disease 36% · Diabetes 33% · Atrial fibrillation 33% · Heart failure 21% · Chronic kidney disease 21% · Cancer 19%.
The office billed $427,305, Medicare allowed $121,775 and paid $95,998; for 673 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 58 | 673 | 75 | 2.55 | $427,305 | $95,998 |
| 2023 | 59 | 1,151 | 75 | 2.72 | $684,210 | $144,817 |
| 2022 | 65 | 700 | 77 | 2.27 | $424,925 | $93,635 |
| 2021 | 37 | 550 | 76 | 1.60 | $331,150 | $71,512 |
| 2020 | 44 | 447 | 77 | 1.78 | $294,280 | $53,121 |
| 2019 | 46 | 163 | 77 | 2.90 | $63,360 | $17,560 |
| 2018 | 34 | 71 | 70 | 3.36 | $22,598 | $6,037 |
| 2016 | 14 | 31 | 73 | 0.91 | $10,405 | $4,327 |
| 2015 | 39 | 108 | 73 | 3.92 | $31,082 | $10,874 |
| 2014 | 86 | 584 | 74 | 3.95 | $195,600 | $52,803 |
| 2013 | 36 | 246 | 75 | 3.34 | $69,363 | $17,251 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 13 | $83,968 | $185 |
| Short return visit (20+ min) | 27 | $11,707 | $82 |
| Management of oxygen chamber therapy | 13 | $10,842 | $92 |
| Return visit (30+ min) | 21 | $9,242 | $116 |
2022: 5 services
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 11 | $52,787 | $187 |
| Return visit (30+ min) | 30 | $14,881 | $117 |
| Management of oxygen chamber therapy | 11 | $6,740 | $94 |
| Short return visit (20+ min) | 23 | $4,010 | $82 |
| New patient visit (45+ min) | 13 | $2,000 | $154 |
2021: 1 service
| Return visit (30+ min) | 15 | $13,255 | $119 |
2020: 4 services
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 14 | $29,271 | $145 |
| Return visit (30+ min) | 12 | $6,233 | $102 |
| Management of oxygen chamber therapy | 14 | $5,119 | $98 |
| New patient visit (30+ min) | 12 | $909 | $76 |
2014: 7 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 35 | $8,036 | $80 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 30 | $5,093 | $61 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 25 | $4,372 | $78 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 23 | $4,102 | $60 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 18 | $2,056 | $114 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 14 | $1,603 | $115 |
| Removal of tissue from wound, 20.0 sq cm or less | 11 | $1,557 | $68 |
2013: 4 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 20 | $2,838 | $59 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 12 | $1,627 | $77 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 13 | $1,450 | $112 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $944 | $79 |
Drugs they prescribed that Part D paid
$2,366
Pharmacies billed $2,366 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
66 generic and fewer than 11 brand-name prescriptions · $2,366 in drug cost · 50 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Doxycycline Hyclate | 19 | $206 | $11 |
| Cephalexin | 18 | $125 | $7 |
Year by year
| 2024 | 70 | 25 | None | None | $2,366 |
| 2023 | 86 | 22 | None | None | $1,446 |
| 2022 | 58 | 28 | None | None | $1,039 |
| 2021 | 59 | 22 | None | 0% | $962 |
| 2020 | 33 | 15 | None | 0% | $748 |
| 2019 | 16 | 11 | None | None | $194 |
| 2018 | 32 | 11 | None | None | $956 |
| 2017 | 20 | None | None | 0% | $100 |
| 2016 | 32 | 14 | None | 0% | $372 |
| 2015 | 31 | 11 | None | None | $715 |
| 2014 | 16 | 11 | None | None | $750 |
| 2013 | 20 | None | None | None | $484 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Doxycycline Hyclate | 13 | $293 | $23 |
| Cephalexin | 29 | $282 | $10 |
2022: 1 drug
| Cephalexin | 23 | $478 | $21 |
2021: 1 drug
| Cephalexin | 45 | $794 | $18 |
2020: 1 drug
| Cephalexin | 11 | $144 | $13 |
2015: 1 drug
| Cephalexin | 12 | $72 | $6 |
Money from drug and device companies
$462 in 2025
| 2025 | 11 | 13 | None | $462 |
| 2024 | 6 | 8 | None | $327 |
| 2023 | 5 | 11 | None | $477 |
| 2022 | 8 | 14 | None | $338 |
| 2021 | 7 | 9 | None | $251 |
| 2020 | 5 | 7 | None | $247 |
| 2019 | 6 | 6 | None | $758 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Rti Surgical | Cortiva Allograft Dermis | $165 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $66 | 3 payments
|
| Genzyme | Dupixent | $37 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $31 | 1 payment
|
| Solventum | Activ.A.C. | $29 | 1 payment
|
| Janssen Biotech | Tremfya | $27 | 1 payment
|
See all 13 published payments
| Novartis Pharmaceuticals | Meals · 2025-11-24 | Cosentyx | $21 |
| Abbvie | Meals · 2025-11-11 | Rinvoq | $26 |
| Incyte | Meals · 2025-10-21 | Opzelura | $16 |
| Smith+Nephew | Meals · 2025-09-09 | Collagenase Santyl | $16 |
| Janssen Biotech | Meals · 2025-07-23 | Tremfya | $27 |
| Molnlycke Health Care US | Meals · 2025-07-18 | Setopress | $24 |
| Rti Surgical | Meals · 2025-07-09 | Cortiva Allograft Dermis | $165 |
| Genzyme | Meals · 2025-06-26 | Dupixent | $37 |
| Smith+Nephew | Meals · 2025-06-17 | Collagenase Santyl | $27 |
| Solventum | Meals · 2025-04-01 | Activ.A.C. | $29 |
| Smith+Nephew | Meals · 2025-02-15 | Collagenase Santyl | $24 |
| Sun Pharmaceutical Industries | Meals · 2025-01-29 | Winlevi | $31 |
| ConvaTec | Meals · 2025-01-10 | Aquacel Foam | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $327
| Aroa Biosurgery | None | $139 | 1 payment
|
| Abbvie | Botox | $79 | 3 payments
|
| Incyte | Opzelura | $32 | 1 payment
|
| Genzyme | Dupixent | $30 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $26 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $21 | 1 payment
|
2023: $477
| Abbvie | Natrelle Saline-Filled Breast Implants | $369 | 7 payments
|
| Merz North America | None | $34 | 1 payment
|
| Lilly USA | Taltz | $29 | 1 payment
|
| Incyte | Opzelura | $24 | 1 payment
|
| Organogenesis | Puraply | $21 | 1 payment
|
2022: $338
| Janssen Biotech | Remicade | $139 | 7 payments
|
| Ucb | Cimzia | $39 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $33 | 1 payment
|
| Lilly USA | Taltz | $32 | 1 payment
|
| Allergan | None | $27 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $24 | 1 payment
|
| Incyte | Opzelura | $23 | 1 payment
|
| ConvaTec | Aquacel Ag+ | $20 | 1 payment
|
2021: $251
| Sun Pharmaceutical Industries | Ilumya | $71 | 3 payments
|
| AcelRx Pharmaceuticals | Dsuvia | $56 | 1 payment
|
| Ucb | Cimzia | $29 | 1 payment
|
| Allergan | Botox | $27 | 1 payment
|
| AbbVie | Skyrizi | $26 | 1 payment
|
| Janssen Biotech | Remicade | $24 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $18 | 1 payment
|
2020: $247
| AcelRx Pharmaceuticals | Dsuvia | $150 | 3 payments
|
| LEO Pharma | Finacea | $29 | 1 payment
|
| VYNE Pharmaceuticals | Amzeeq | $27 | 1 payment
|
| AbbVie | Skyrizi | $22 | 1 payment
|
| Smith+Nephew | Santyl | $18 | 1 payment
|
2019: $758
| AngioDynamics | Evlt | $660 | 1 payment
|
| Dermira | None | $26 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Altreno | $23 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $19 | 1 payment
|
| Smith+Nephew | Santyl | $18 | 1 payment
|
| DUSA Pharmaceuticals | Levulan Kerastick | $12 | 1 payment
|
Professional record
- NPI
- 1164521605
- Licence
- CA G9257California G9257: Current · expires 2028-10-31
- Trained
- Yale University School of Medicine, 1962 · 64 years ago
- Group
- Hyperbaric Consultants Medical Group Inc · Csi Medical Group
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 208200000X (208200000X)
- Mailing address
- 3562 Round Barn Cir Ste 320, Santa Rosa, CA, 95403
- NPI first listed
- 2006-09-21
- NPI last updated
- 2024-03-12
- NPI record certified
- 2024-03-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3838 California St Rm 610, San Francisco, CA, 94118